Alzheimer disease in the United States (2010-2050) estimated using the 2010 census. - Wikidata - wikimedia - TriplyDB

Alzheimer disease in the United States (2010-2050) estimated using the 2010 census.

Alzheimer disease in the United States (2010-2050) estimated using the 2010 census.

http://www.wikidata.org/entity/Q37035610

about

Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia within a secondary care setting Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the early diagnosis of dementia across a variety of healthcare settings Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia within a general practice (primary care) setting AD-8 for diagnosis of dementia across a variety of healthcare settings IQCODE for the diagnosis of Alzheimer’s disease dementia and other dementias within a general practice (primary care) setting IQCODE for the diagnosis of Alzheimer’s disease dementia and other dementias within a secondary care setting Neurotrophic factor small-molecule mimetics mediated neuroregeneration and synaptic repair: emerging therapeutic modality for Alzheimer's disease CB2 Cannabinoid Receptor As Potential Target against Alzheimer's Disease Docosahexaenoic Acid and Cognition throughout the Lifespan Amyloid positron emission tomography and cognitive reserve Bilingualism and Cognitive Reserve: A Critical Overview and a Plea for Methodological Innovations Clinical management of sleep disturbances in Alzheimer's disease: current and emerging strategies Friends or Foes: Matrix Metalloproteinases and Their Multifaceted Roles in Neurodegenerative Diseases Patients who share transparent visit notes with others: characteristics, risks, and benefits Molecular determinants of blood-brain barrier permeation Applications of Induced Pluripotent Stem Cells in Studying the Neurodegenerative Diseases Autosomal Dominant Alzheimer Disease: A Unique Resource to Study CSF Biomarker Changes in Preclinical AD Recent advances in the application of metabolomics to Alzheimer's Disease The relevance of beta-amyloid on markers of Alzheimer's disease in clinically normal individuals and factors that influence these associations Brain stimulation for combating Alzheimer's disease ACE overexpression in myelomonocytic cells: effect on a mouse model of Alzheimer's disease Improving and accelerating drug development for nervous system disorders Proteolytic cleavage of apolipoprotein E4 as the keystone for the heightened risk associated with Alzheimer's disease When Mars Versus Venus is Not a Cliché: Gender Differences in the Neurobiology of Alzheimer's Disease Metformin promotes tau aggregation and exacerbates abnormal behavior in a mouse model of tauopathy Passive immunization with phospho-tau antibodies reduces tau pathology and functional deficits in two distinct mouse tauopathy models Differential contributions of ApoE4 and female sex to BACE1 activity and expression mediate Aβ deposition and learning and memory in mouse models of Alzheimer's disease Self-Organizing 3D Human Neural Tissue Derived from Induced Pluripotent Stem Cells Recapitulate Alzheimer's Disease Phenotypes qPR: An adaptive partial-report procedure based on Bayesian inference.Neurocognitive testing and cochlear implantation: insights into performance in older adults.Relationship Between Antihypertensive Medications and Cognitive Impairment: Part II. Review of Physiology and Animal Studies CLINICAL PRACTICE. Advanced Dementia Public perceptions about risk and protective factors for cognitive health and impairment: a review of the literature The Ubiquitin-Proteasome System and Molecular Chaperone Deregulation in Alzheimer's Disease Occupational cognitive requirements and late-life cognitive aging Regulation of proteasome activity in health and disease Interactions between inflammation, sex steroids, and Alzheimer's disease risk factors Genetic variants in Alzheimer disease - molecular and brain network approaches Direct and indirect cost of managing alzheimer's disease and related dementias in the United States.Pathophysiologic relationship between Alzheimer's disease, cerebrovascular disease, and cardiovascular risk: A review and synthesis

P2860

Q24187059-647D1CAF-A483-4DCE-858A-DBA31303170E Q24193211-730B3614-F798-49FF-886B-28453DA061CA Q24194747-E392F94F-20BE-4524-93E3-99185F940C48 Q24194796-33DC2866-EBF9-4852-8916-CA1239112163 Q24197665-9E5DD1C1-D59B-4093-A7E7-B869084AB5A8 Q24197672-71882E03-ED98-4F91-B602-59D086B72B69 Q26741247-C619B76E-1E8A-40F3-9146-90F562A304E8 Q26746050-C49BF638-0087-4D68-9428-23FF51B8C36F Q26768442-24262298-1167-4629-89AE-AC4C5E3F3E85 Q26769755-98F9BCEB-1B6C-4107-B0AC-FE80E0E02FDC Q26770439-C2DCADE6-782D-4FD2-BA6A-C7E68BD95DA9 Q26772851-1295EEF1-1D45-44F6-9370-BED5AC28D4DF Q26779933-3A159D5B-B811-4552-9910-EE1A799E80FC Q26782426-750ACE20-D9B3-4F65-9F8F-916FF3814566 Q26797482-A5BBE7B7-6FE5-4357-87B1-C156221860F7 Q26799331-98CC9003-DADA-45DD-B8D3-01CC64D4C2C8 Q26801666-8552E898-4087-4918-82D8-511F24DC80F5 Q26828606-F245432D-D2DE-4011-8CA1-7A6C90BA9F27 Q26830467-A673E8F0-2DEE-4FBE-A4A3-385CE79B8271 Q26863760-D9D14D34-2C1B-4FE6-BAE4-11806145BD60 Q26866225-A11CAB2E-F5A9-4C3B-B832-3082F09E90DA Q27008349-46A523AF-B916-4B5D-BB2F-6C06FA811417 Q27011311-288610A6-4BB7-4835-A1A4-8BBC1FC5716C Q27021193-1DEEDE24-9E65-44CE-BBFA-F6BAA3A5851B Q27301246-898E7690-FBAB-4B53-8FD1-0D3046FFEB10 Q27308146-19AB840D-FA13-48E1-A430-777FD17F0749 Q27323892-34AD44BC-0462-41CC-9E24-B5E61FDBE42E Q27324311-36195D8D-EC17-4A5D-ADF0-96036724214E Q27335564-AFCD595A-836D-46B4-AE87-5517E4CA27BB Q27339374-3F39CE84-9855-4491-A62B-7790F97A495A Q28074637-214FF5B5-81E1-4B06-BF87-4B2AAE021364 Q28082593-CE8D2750-726A-49DE-9B90-1BA20DE1DD0E Q28085649-71364A42-7343-4F15-B8F7-03D377753CBA Q28254943-D2EDE8C5-705D-4221-A3C1-C75F11801ACD Q28392179-3CEF3034-EA1F-4B88-A0CC-69A56D0D41FC Q28392708-4D5B6107-98C7-46AB-87D8-BAD6C1FCFC02 Q28394967-659679B6-63ED-4867-948A-4F5956AFB1E4 Q28596011-689D4C22-C0BD-4878-B4B2-9F2BB184C9E2 Q30235057-1676A3CB-698B-4EBD-96D7-A6FED674C393 Q30235369-F44FD014-4A06-40E1-A05C-D406FD02E013

P2860

Alzheimer disease in the United States (2010-2050) estimated using the 2010 census.

http://www.wikidata.org/entity/Q37035610

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 06 February 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Alzheimer disease in the United States (2010-2050) estimated using the 2010 census.

@en

Alzheimer disease in the United States

@nl

type

label

Alzheimer disease in the United States (2010-2050) estimated using the 2010 census.

@en

Alzheimer disease in the United States

@nl

prefLabel

Alzheimer disease in the United States (2010-2050) estimated using the 2010 census.

@en

Alzheimer disease in the United States

@nl

P1433

Q37035610-B73352FE-9928-4160-8B9E-92A1ED4B9FDC

P1476

Q37035610-9897DAB8-5D43-44C8-8CC5-B8237D862FF6

P2093

Q37035610-1B871FEC-9F17-496D-AC96-0BFF6A796373

Q37035610-2421DDE4-C967-4AE0-B9DD-D6EA9D3FA3DC

Q37035610-35994AE8-314A-4024-8471-F7ECD204C8FC

Q37035610-D3C53F7D-45DC-4DB8-B013-1D9C836673F1

P2860

Q37035610-08A36F58-1BCE-48C6-ABEE-817D802F3AEC

Q37035610-0EE2BAC7-B020-4100-85F5-55E22446A981

Q37035610-154D8828-E613-4BCD-8367-E2867F22D417

Q37035610-18AA2904-3BCD-43C6-93CF-6C9EDE9B6A6F

Q37035610-62F9A82B-2F22-418C-A478-ABAC369AADAE

Q37035610-88BBD86D-5A6F-402B-A867-F4137E488002

Q37035610-89CC8C79-50C4-4064-BAF7-AFD319D70807

Q37035610-932D5C6A-A50D-45FD-8AAE-E6C485F569DE

Q37035610-93FDBC4B-A451-47FA-8F87-34DFA078B043

Q37035610-B46C977C-A56F-42C4-BB03-86F96C8A9ED7

P304

Q37035610-B0A43AC3-8C6A-4541-87D5-FA584BC07FCA

P31

Q37035610-3D792212-0B0A-4ED6-9812-A88E102EDDF2

P356

Q37035610-8BBD51CA-9380-4A04-A106-BB089FFED420

P407

Q37035610-E47646D2-50F6-4B5D-8386-5B0000D2F14A

P433

Q37035610-3BEC04BC-C7F0-44C0-9A1F-FD81B6A01B59

P478

Q37035610-F8697301-7FC6-4F79-A526-99D37F9A8B55

P577

Q37035610-DC4B4BAA-8DD5-4C7C-A1F6-39E324209A9A

P698

Q37035610-4B97325D-2BAA-4C39-A4B8-4E1962BEEEC7

P921

Q37035610-3D3F05A5-5015-42E6-B34A-1B9392A29054

Q37035610-AFE326EE-2497-4301-BE4E-FF9A9A3B99A8

P932

Q37035610-6883266B-6595-4B1D-924C-ADD5510A9D5C

P356

WNL.0B013E31828726F5

P1433

P1476

Alzheimer disease in the United States (2010-2050) estimated using the 2010 census.

@en

P2093

Denis A Evans

http://www.w3.org/2001/XMLSchema#string

Jennifer Weuve

http://www.w3.org/2001/XMLSchema#string

Liesi E Hebert

http://www.w3.org/2001/XMLSchema#string

Paul A Scherr

http://www.w3.org/2001/XMLSchema#string

P2860

Alzheimer Disease in the US Population

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Prevalence of dementia in the United States: the aging, demographics, and memory study.

National estimates of the prevalence of Alzheimer's disease in the United States.

Sources of variability in estimates of the prevalence of Alzheimer's disease in the United States.

Missed and delayed diagnosis of dementia in primary care: prevalence and contributing factors.

Incidence of Alzheimer disease in a biracial urban community: relation to apolipoprotein E allele status.

Design of the Chicago Health and Aging Project (CHAP).

Estimated prevalence of Alzheimer's disease in the United States.

Age-specific incidence of Alzheimer's disease in a community population.

P304

1778-1783

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1212/WNL.0B013E31828726F5

http://www.w3.org/2001/XMLSchema#string

P407

P433

19

http://www.w3.org/2001/XMLSchema#string

P478

80

http://www.w3.org/2001/XMLSchema#string

P577

2013-02-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23390181

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

Ameeriga Ütisriigiq

P932

3719424

http://www.w3.org/2001/XMLSchema#string